nebivolol vs propafenone
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of nebivolol and propafenone. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
( 7.4 ) 7.1 CYP2D6 Inhibitors Use caution when nebivolol is co-administered with CYP2D6 inhibitors (quinidine, propafenone, fluoxetine, paroxetine, etc.) [ see Clinical Pharmacology ( 12.5 ) ].
Bystolic
Rythmol
Nebivolol is a medicine that lowers high blood pressure. Lowering blood pressure helps prevent strokes and heart attacks.
Propafenone (Rythmol) is a medicine that helps control irregular heartbeats. It works by slowing down electrical signals in the heart.
Nebivolol treats high blood pressure. High blood pressure increases your risk of heart attack and stroke. Nebivolol can be used alone or with other blood pressure medicines.
This medicine is used to help keep your heart rhythm normal if you have atrial fibrillation or supraventricular tachycardia. These are types of fast or irregular heartbeats that can cause problems. It can also treat life-threatening ventricular arrhythmias. Propafenone is for people without structural heart disease.
Nebivolol is a beta-blocker that mainly affects the heart. It works by relaxing blood vessels and slowing down your heart rate. This makes it easier for your heart to pump blood and lowers blood pressure.
Propafenone works by affecting the electrical activity in your heart. It slows down the signals that cause irregular heartbeats. This helps your heart beat more regularly.
- • Headache
- • Tiredness
- • Dizziness
- • Diarrhea
- • Nausea
- • Unusual taste
- • Nausea
- • Vomiting
- • Dizziness
- • Constipation
- Acute Kidney Injury 922
- Dyspnoea 773
- Diarrhoea 724
- Drug Interaction 616
- Hypotension 611
- Atrial Fibrillation 347
- Drug Interaction 320
- Dizziness 262
- Toxicity To Various Agents 231
- Dyspnoea 226
Do not stop taking nebivolol suddenly if you have heart disease. This can make chest pain worse or cause a heart attack. Talk to your doctor before stopping nebivolol. They will likely lower your dose slowly over 1 to 2 weeks.
This medicine may increase the risk of death in people with heart problems. Do not take this medicine if you have structural heart disease and non-life-threatening ventricular arrhythmias. Talk to your doctor about the risks and benefits of taking this medicine.
Talk to your doctor if you are pregnant or plan to become pregnant. Nebivolol may cause problems for the baby, such as low blood pressure or slow heart rate. Breastfeeding is not recommended while taking nebivolol.
Tell your doctor if you are pregnant or plan to become pregnant. This medicine can cross the placenta, and may affect the baby. Your doctor will monitor you and your baby for any problems.
Also Compare, Nearby Drugs
Compare nebivolol with
Compare propafenone with
How to Read This nebivolol vs propafenone Comparison
nebivolol is classified in the Beta-1 Selective Blocker drug class, while propafenone sits within the Class IC Antiarrhythmic class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, nebivolol has 3,646 submissions while propafenone has 1,386. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to propafenone slows down the body's ability to process nebivolol, which could cause the medication to build up to higher levels.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for nebivolol or propafenone.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.